[1]周腾飞,朱良付,李天晓.影响急性缺血性脑卒中血管内治疗预后的相关因素分析[J].介入放射学杂志,2017,(02):99-104.
 ZHOU Tengfei,ZHU Liangfu,LI Tianxiao.Analysis of factors influencing the prognosis of patients with acute ischemic stroke receiving endovascular treatment[J].journal interventional radiology,2017,(02):99-104.
点击复制

影响急性缺血性脑卒中血管内治疗预后的相关因素分析()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2017年02期
页码:
99-104
栏目:
专论
出版日期:
2017-02-25

文章信息/Info

Title:
Analysis of factors influencing the prognosis of patients with acute ischemic stroke receiving endovascular treatment
作者:
周腾飞 朱良付 李天晓
Author(s):
ZHOU Tengfei ZHU Liangfu LI Tianxiao
Department of Interventional Therapy, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital, Zhengzhou, Henan Province 450003, China
关键词:
【关键词】 急性缺血性脑卒中 血管内治疗 预后因素
文献标志码:
A
摘要:
【摘要】 随着多项大型临床试验研究结果发布,血管内治疗(或联合静脉溶栓)被推荐为颅内大血管闭塞所致急性缺血性脑卒中患者首选治疗措施。然而,血管内再通治疗预后受到一系列因素影响。该文就影响血管内治疗预后的可能因素作一综述。

参考文献/References:

[1] Mulder MJ, van Oostenbrugge RJ, Dippel DW, et al. Letter by Mulder et al, Regarding article,“2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: A guideline for healthcare professionals from the American Heart Association/American Stroke Association”[J]. Stroke, 2015, 46: e235.
[2] 高 峰, 徐安定. 急性缺血性卒中血管内治疗中国指南2015[J]. 中国卒中杂志, 2015, 10: 590?-606.
[3] Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2013, 44: 870?-947.
[4] Clark WM, Wissman S, Albers GW, et al. Recombinant tissue?-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke[J]. JAMA, 1999, 282: 2019?-2026.
[5] Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. J Vasc Surg, 2008, 48: 1634?-1635.
[6] Xu AD, Wang YJ, Wang DZ, et al. Consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel[J]. CNS Neurosci Ther, 2013, 19: 543?-548.
[7] Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t?-PA versus t?-PA alone for stroke[J]. N Engl J Med, 2013, 368: 893?-903.
[8] Ciccone A, Valvassori L, Investigators SE. Endovascular treatment for acute ischemic stroke[J]. N Engl J Med, 2013, 368: 2433?-2444.
[9] Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke[J]. N Engl J Med, 2013, 368: 914?-923.
[10] Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med, 2015, 372: 11?-20.
[11] Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion?-imaging selection[J]. N Engl J Med, 2015, 372: 1009?-1018.
[12] Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med, 2015, 372: 1019?-1030.
[13] Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med, 2015, 372: 2296?-2306.
[14] Saver JL, Goyal M, Bonafe A, et al. Stent?-retriever thrombectomy after intravenous t?-PA vs. t?-PA alone in stroke[J]. N Engl J Med, 2015, 372: 2285?-2295.
[15] Levy EI, Siddiqui AH, Crumlish A, et al. First Food and Drug Administration?-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent?-assisted recanalization in acute ischemic stroke)[J]. Stroke, 2009, 40: 3552?-3556.
[16] Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score[J]. Lancet, 2000, 355: 1670?-1674.
[17] Demchuk AM, Hill MD, Barber PA, et al. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study[J]. Stroke, 2005, 36: 2110?-2115.
[18] Yoo AJ, Zaidat OO, Chaudhry ZA, et al. Impact of pretreatment noncontrast CT Alberta Stroke Program Early CT Score on clinical outcome after intra?-arterial stroke therapy[J]. Stroke, 2014, 45: 746?-751.
[19] Hacke W, Kaste M, Fieschi C, et al. Randomised double?-blind placebo?-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke(ECASSⅡ). Second European?-Australasian Acute Stroke Study Investigators[J]. Lancet, 1998, 352: 1245?-1251.
[20] Thijs VN, Lansberg MG, Beaulieu C, et al. Is early ischemic lesion volume on diffusion?-weighted imaging an independent predictor of stroke outcome? A multivariable analysis[J]. Stroke, 2000, 31: 2597?-2602.
[21] Zaidi SF, Aghaebrahim A, Urra X, et al. Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy[J]. Stroke, 2012, 43: 3238?-3244.
[22] Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study[J]. Lancet Neurol, 11: 860?-867.
[23] Smith WS, Lev MH, English JD, et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA[J]. Stroke, 2009, 40: 3834?-3840.
[24] Zheng F, Xie WX. Imaging?-Based patient selection and endovas?蛳cular therapy of ischemic stroke: a stratified Meta?蛳Analysis[J]. Medicine (Baltimore), 2015, 94: e1539.
[25] Cooray C, Fekete K, Mikulik R, et al. Threshold for NIH stroke scale in predicting vessel occlusion and functional outcome after stroke thrombolysis[J]. Int J Stroke, 2015, 10: 822?-829.
[26] Bang OY, Saver JL, Kim SJ, et al. Collateral flow predicts response to endovascular therapy for acute ischemic stroke[J]. Stroke, 2011, 42: 693?-699.
[27] Liebeskind DS, Jahan R, Nogueira RG, et al. Impact of collaterals on successful revascularization in Solitaire FR with the intention for thrombectomy[J]. Stroke, 2014, 45: 2036?-2040.
[28] Lees KR, Bluhmki E, Von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, Atlantis, NINDS, and EPITHET trials[J]. Lancet, 2010, 375: 1695?-1703.
[29] Hassan AE, Chaudhry SA, Miley JT, et al. Microcatheter to recanalization(procedure time) predicts outcomes in endovascular treatment in patients with acute ischemic stroke: when do we stop?[J]. AJNR Am J Neuroradiol, 2013, 34: 354?-359.
[30] Mosimann PJ, Sirimarco G, Meseguer E, et al. Is intracerebral hemorrhage a time?-dependent phenomenon after successful com?-bined intravenous and intra?-arterial therapy?[J]. Stroke, 2013, 44: 806?-808.
[31] Mazighi M, Chaudhry SA, Ribo M, et al. Impact of onset?-to?-reperfusion time on stroke mortality: a collaborative pooled analysis[J]. Circulation, 2013, 127: 1980?-1985.
[32] Abou?-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients[J]. Stroke, 2010, 41: 1996?-2000.
[33] Alshekhlee A, Pandya DJ, English J, et al. Merci mechanical thrombectomy retriever for acute ischemic stroke therapy:literature review[J]. Neurology, 2012, 79(13 Suppl 1): S126?-S134.
[34] Todo A, Minaeian A, Sahni R, et al. Incidence and outcome of procedural distal emboli using the Penumbra thrombectomy for acute stroke[J]. J Neurointerv Surg, 2013, 5: 135?-138.
[35] 王洪生, 刘 圣, 赵林波, 等. Solitaire AB型支架取栓治疗急性大脑中动脉栓塞疗效分析[J]. 介入放射学杂志, 2015, 24: 658?-661.
[36] Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel?-group, non?-inferiority trial[J]. Lancet, 2012, 380: 1241?-1249.
[37] Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial[J]. Lancet, 2012, 380: 1231?-1240.
[38] Almekhlafi MA, Menon BK, Freiheit EA, et al. A meta?-analysis of observational intra?-arterial stroke therapy studies using the Merci device, Penumbra system, and retrievable stents[J]. AJNR Am J Neuroradiol, 2013, 34: 140?-145.
[39] Grech R, Pullicino R, Thornton J, et al. An efficacy and safety comparison between different stentriever designs in acute ischaemic stroke: a systematic review and meta?-analysis[J]. Clin Radiol, 2016, 71: 48?-57.
[40] Bhatnagar P, Sinha D, Parker RA, et al. Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta?-analysis to aid decision making in patients over 80 years of age[J]. J Neurol Neurosurg Psychiatry, 2011, 82: 712?-717.
[41] Duffis EJ, He W, Prestigiacomo CJ, et al. Endovascular treatment for acute ischemic stroke in octogenarians compared with younger patients: a meta?-analysis[J]. Int J Stroke, 2014,9: 308?-312.
[42] Zacharatos H, Hassan AE, Vazquez G, et al. Comparison of acute nonthrombolytic and thrombolytic treatments in ischemic stroke patients 80 years or older[J]. Am J Emerg Med, 2012, 30: 158?-164.
[43] Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial[IST?-3]): a randomised controlled trial[J]. Lancet, 2012, 379: 2352?-2363.
[44] Pan YE, Chen QD, Liao XL, et al. Preexisting dual antiplatelet treatment increases the risk of post?-thrombolysis intracranial hemorrhage in Chinese stroke patients[J]. Neurol Res, 2015, 37: 64?-68.
[45] Pan X, Zhu Y, Zheng D, et al. Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta?-analysis of cohort studies and randomized controlled trials[J]. Int J Stroke, 2015, 10: 317?-323.
[46] Kellert L, Hametner C, Rohde S, et al. Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome[J]. Stroke, 2013, 44: 1453?-1455.
[47] Kim JW, Jeon P, Kim GM, et al. Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: preliminary experience and short term follow?-up results[J]. Clin Neurol Neurosurg, 2012, 114: 1316?-1319.
[48] Seo JH, Jeong HW, Kim ST, et al. Adjuvant tirofiban injection through deployed solitaire stent as a rescue technique after failed mechanical thrombectomy in acute stroke[J]. Neurointervention, 2015, 10: 22?-27.
[49] Almekhlafi MA, Davalos A, Bonafe A, et al. Impact of age and baseline NIHSS scores on clinical outcomes in the mechanical thrombectomy using Solitaire FR in acute ischemic stroke study[J]. AJNR Am J Neuroradiol, 2014, 35: 1337?-1340.
[50] Abou?-Chebl A, Lin R, Hussain MS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study[J]. Stroke, 2010, 41: 1175?-1179.

相似文献/References:

[1]唐军,明德国,刘作勤,等.脑动静脉畸形的血管内栓塞治疗[J].介入放射学杂志,2000,(03):144.
[2]黄求理,宋侃侃,施建国,等.血管内治疗基底动脉瘤并发短暂双目失明1例[J].介入放射学杂志,1997,(04):244.
[3]李明华,陈君彦,顾斌贤,等.颅内动脉瘤可解脱弹簧栓塞治疗——附28例分析[J].介入放射学杂志,1998,(04):194.
[4]魏崇健,何洪林,乔英,等.创伤性假性动脉瘤与动静脉瘘的介入治疗(附25例报告)[J].介入放射学杂志,1999,(03):19.
[5]黄正松,戴钦舜.血管内治疗颅内动脉瘤[J].介入放射学杂志,1994,(02):104.
[6]王 武,李明华,顾斌贤.Solitaire AB支架血管内治疗支架源性弹簧圈移位的脑动脉瘤一例[J].介入放射学杂志,2010,(10):804.
 WANG Wu,LI Ming-hua,GU Bin-xian..Solitaire AB stent management of coil migration associated with stent-assisted coiling of a cerebral aneurysm: report of one case[J].journal interventional radiology,2010,(02):804.
[7]何永福,王武,李明华,等.颈内动脉眼动脉段血泡样动脉瘤合并右位主动脉弓一例[J].介入放射学杂志,2010,(12):1007.
 HE Yong-fu,WANG Wu,LI Ming-hua,et al.A blister-like aneurysm at the ophthalmic segment of internal carotid artery associated with right-sided aortic arch: report of one case[J].journal interventional radiology,2010,(02):1007.
[8]王兴华,王武,陈新国,等.血管内栓塞治疗脊髓血管畸形[J].介入放射学杂志,2010,(12):933.
 WANG Xing-hua,WANG Wu,CHEN Xin-guo,et al.Endovascular embolization for spinal cord vascular malformation[J].journal interventional radiology,2010,(02):933.
[9]王 武,李明华,顾斌贤.Willis覆膜支架治疗难治性外伤性颈动脉海绵窦瘘[J].介入放射学杂志,2011,(03):177.
 WANG Wu,LI Ming-hua,GU Bin-xian..Endovascular treatment of complex traumatic direct carotid-cavernous fistulas by using Willis covered stent[J].journal interventional radiology,2011,(02):177.
[10]张智博,杨鹏飞,黄清海,等.创伤性颅内假性动脉瘤的血管内治疗[J].介入放射学杂志,2011,(04):329.
 ZHANG Zhi-bo,YANG Peng-fei,HUANG Qing-hai,et al.Endovascular treatment of traumatic intracranial pseudoaneurysm[J].journal interventional radiology,2011,(02):329.

备注/Memo

备注/Memo:
(收稿日期:2016-04-22)
(本文编辑:边 佶)
更新日期/Last Update: 2017-02-13